Both in Pharmaceuticals
Context Therapeutics vs Edesa Biotech
Over the past year CNTX returned −81.9% and EDSA returned +18.5%; their daily moves had a correlation of 0.05.
CNTX −81.9% EDSA +18.5%Growth of $1, one year, split-adjusted
| Metric | CNTX | EDSA |
|---|---|---|
| Price | $0.2113 | $2.56 |
| Market cap | $19.4M | $24.7M |
| Today | −9.97% | −2.66% |
| 1 month | −33.8% | −28.1% |
| 6 months | −91.0% | −83.9% |
| Year to date | −85.6% | +80.3% |
| 1 year | −82.8% | −2.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $43.0M | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 94.9% | 87.9% |
| Short % of float | 6.2% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).